PortViewPortView
BSJN logo

Invesco BulletShares 2023 High Yield Corporate Bond (BSJN) ETF Holdings & Analysis

ETFOther

$23.49+0.04%
1-year price historyRange $23.07 – $23.61
52-week range$23.49
$23.28$23.63

What BSJN does

The fund allocates at least 80% of its total capital to securities that replicate its benchmark index. This index is engineered to track the returns of a portfolio comprising U.S. dollar-denominated high-yield corporate bonds, commonly known as "junk bonds," which are scheduled to mature or have an "effective maturity" during 2023. These specific bond holdings are collectively designated as "2023 Bonds."

Fund profile

Category
Other
AUM
$434.67M
Holdings
1
52-week high
$23.63
52-week low
$23.28

Top holdings

HoldingWeight
Cash/Receivables/Payables100.00%

Sector allocation

Cash & Others100.00%

Geographic allocation

Other100.00%

PortView Portfolio Insights

PortView analyzes how BSJN fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BSJN in PortView →

Related securities

Related stocks

Frequently asked questions

What does BSJN track?
BSJN is the Invesco BulletShares 2023 High Yield Corporate Bond ETF, a Other ETF.
What is the expense ratio of BSJN?
Expense ratio data for BSJN is shown on the page when available from our data provider.
What are the largest holdings in BSJN?
Top holdings include -CASH-.
How can PortView analyze BSJN overlap with other ETFs?
PortView computes the holdings overlap between BSJN and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.